SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2974)2/24/2001 1:57:59 AM
From: Torben Noerup Nielsen  Read Replies (2) | Respond to of 52153
 
Doesn't such a study depend primarily on the cDNA rather than on the DNA itself?

I am willing to believe that the number of genes we have is relatively low. But that doesn't put much of a limit on the number of proteins we can make.....

Torben



To: Biomaven who wrote (2974)2/24/2001 4:36:46 PM
From: tuck  Read Replies (1) | Respond to of 52153
 
And while we're on the subject of genomic based drug discovery, here's part two of GenomeWeb's series on how to patent one:

TRENDSPOTTER: How to Overcome the Hurdles to Patentability ? Part II

genomeweb.com

Come spring, when it stops raining on weekends here in SoCal, y'all will have to find this weekend reading by yourselves. I'll be cragging a lot more then.

Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News